FDA warns Salon Technologies International that its hand sanitizers contained unacceptable acetaldehyde, acetal and benzene impurities and were adulterated.
What happened
FDA conducted laboratory testing of a batch of Salon Technologies International Sanitizing Hand Spray 80% in U.S. distribution and found acetaldehyde and acetal at about 739 ppm and 988 ppm. After FDA's June 24, 2022 letter, the firm provided retain-sample impurity results on September 2, 2022, showing benzene at about 12 ppm in Antica Farmacista Hand Sanitizer Ocean Citron. On September 17, 2022, the firm issued a voluntary nationwide recall of one lot of each product.
What FDA found
FDA laboratory testing of a U.S.-distributed batch of Salon Technologies International Sanitizing Hand Spray 80% found acetaldehyde and acetal at about 739 ppm and 988 ppm, above the USP limit of 10 ppm.
section 501(a)(2)(B) of the FD&C Act; 21 CFR 211.160(b); 21 CFR 211.165The firm's own retain-sample test results for Antica Farmacista Hand Sanitizer Ocean Citron found benzene at about 12 ppm.
section 501(a)(2)(B) of the FD&C ActThe firm did not test active pharmaceutical ingredients or finished hand sanitizer for acetal, acetaldehyde, or benzene before distribution.
21 CFR 211.160(b); 21 CFR 211.165The firm lacked a finished-product specification for acetaldehyde and acetal even though alcohol is a significant component of the drug product.
21 CFR 211.160(b)The firm did not perform finished-product testing of each batch for acetaldehyde, acetal, and benzene.
21 CFR 211.165
What FDA wants
FDA tells the firm to respond in writing within 15 working days with a detailed impurity investigation, a list of all raw materials and suppliers, and complete batch records for all U.S.-distributed batches, and to correct violations promptly; FDA also recommends a qualified current good manufacturing practice (CGMP) consultant if the firm resumes U.S. drug manufacturing.
Who should pay attention
- brands that buy finished hand sanitizer from contract manufacturers
- retailers and distributors selling hand sanitizers
- drug manufacturers using alcohol ingredients with impurity risks
This is a summary. Read the original letter on fda.gov.